New biologic markers in non-Hodgkin's lymphomas

T. M. Grogan, T. P. Miller

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


Recent studies suggest lymphoma surface and nuclear markers may be of both diagnostic and prognostic relevance. Specifically relevant are markers of tumor proliferation (Ki67), histocompatibility antigen (HLA), cell lineage (B versus T), and cell adhesion molecules (CD 22,44,56). Additionally, host response as measured by CD8 may be relevant to lymphoma relapse. Collectively, these tumor and host markers suggest new targets for 'phenotype-directed' therapy.

Original languageEnglish (US)
Pages (from-to)925-933
Number of pages9
JournalHematology/Oncology Clinics of North America
Issue number5
StatePublished - 1991

ASJC Scopus subject areas

  • Hematology
  • Oncology


Dive into the research topics of 'New biologic markers in non-Hodgkin's lymphomas'. Together they form a unique fingerprint.

Cite this